N-[[1-[[2-(4-chlorophenyl)-4-oxochromen-6-yl]methyl]triazol-4-yl]methyl]-4-methylbenzamide
C27H21ClN4O3 — CID 123131735
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[[1-[[2-(4-chlorophenyl)-4-oxochromen-6-yl]methyl]triazol-4-yl]methyl]-4-methylbenzamide
N-[[1-[[2-(4-chlorophenyl)-4-oxochromen-6-yl]methyl]triazol-4-yl]methyl]-4-methylbenzamide (PubChem CID 123131735) has the molecular formula C27H21ClN4O3 and a molecular weight of 484.94 g/mol. Its IUPAC name is N-[[1-[[2-(4-chlorophenyl)-4-oxochromen-6-yl]methyl]triazol-4-yl]methyl]-4-methylbenzamide.
Molecular Properties
| Compound Name | N-[[1-[[2-(4-chlorophenyl)-4-oxochromen-6-yl]methyl]triazol-4-yl]methyl]-4-methylbenzamide |
|---|---|
| PubChem CID | 123131735 |
| Molecular Formula | C27H21ClN4O3 |
| Molecular Weight | 484.94 g/mol |
| Exact Mass | 484.13 |
| IUPAC Name | N-[[1-[[2-(4-chlorophenyl)-4-oxochromen-6-yl]methyl]triazol-4-yl]methyl]-4-methylbenzamide |
| SMILES | Cc1ccc(C(=O)NCc2cn(Cc3ccc4oc(-c5ccc(Cl)cc5)cc(=O)c4c3)nn2)cc1 |
| InChI | InChI=1S/C27H21ClN4O3/c1-17-2-5-20(6-3-17)27(34)29-14-22-16-32(31-30-22)15-18-4-11-25-23(12-18)24(33)13-26(35-25)19-7-9-21(28)10-8-19/h2-13,16H,14-15H2,1H3,(H,29,34) |
| InChIKey | BWNZGCPZVFEYFT-UHFFFAOYSA-N |
| XLogP | 4.99 |
| TPSA | 90.02 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 484.94 |
| LogP ≤ 5 | 4.99 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 123131735 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.